Showing results (1-10 of 475) with videos related to
Sort By:
Pageof 48
The Journal of Experimental Medicine|March 1, 1989
The tumor-rejection antigens of the 1591 ultraviolet fibrosarcoma. Potential origin and evolutionary implicationsR Linsk, S Watts, A Fischer, et al.Genetics|December 1, 1990
Gene conversion in the evolution of both the H-2 and Qa class I genes of the murine major histocompatibility complexM Kuhner, S Watts, W Klitz, et al.The EMBO Journal|June 1, 1989
Organization and structure of the Qa genes of the major histocompatibility complex of the C3H mouse: implications for Qa function and class I evolutionS Watts, A C Davis, B Gaut, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1987
DNA sequence analysis of the C3H H-2Kk and H-2Dk loci. Evolutionary relationships to H-2 genes from four other mouse strainsS Watts, J M Vogel, W D Harriman, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1979
Characterization of the reverse transcriptase of a type C RNA virus produced by a human lymphoma cell lineR S Goodenow, H S KaplanThe Journal of Experimental Medicine|November 1, 1985
Molecular basis of the dm1 mutation in the major histocompatibility complex of the mouse: a D/L hybrid geneY H Sun, R S Goodenow, L HoodScience (New York, N.Y.)|November 15, 1985
Histocompatibility antigens on murine tumorsR S Goodenow, J M Vogel, R L LinskImmunogenetics|January 1, 1989
A novel H-2K splice form: predictions for other alternative H-2 splicing eventsJ M Vogel, R Y Morse, R S GoodenowInternational Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1991
T-cell subset analysis of 3LL tumor growthC Gelber, L Eisenbach, M Feldman, et al.Cancer Research|December 1, 1992
T-cell subset analysis of Lewis lung carcinoma tumor rejection: heterogeneity of effectors and evidence for negative regulatory lymphocytes correlating with metastasisC Gelber, L Eisenbach, M Feldman, et al.Pageof 48